BridgeMD
New treatment option for Dermatitis
Official title HYPNOsis in the Management of Atopic Dermatitis in Children and Teenagers
ClinicalTrials.gov ID: NCT05611346
What this study is testing
- What it's testing
- Atopic dermatitis (AD) is a chronic inflammatory dermatosis, common in children. It causes pruritus and skin lesions that can have a significant impact on patients' quality of life.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 17
You may be able to join if
- Children aged 8 to 17 years
- Understanding french
- Have a clinical diagnosis of mild-to-severe AD with a SCORing Atopic Dermatitis (SCORAD)
- Referred by their referring physician in the Reunionese therapeutic education program for AD provided within the atopy school of the Reunion...
You likely can't join if
- Children refusing to participate in the hypnosis session
- Not having the possibility to listen to an audio file,
- Already practicing self-hypnosis for their AD before inclusion,
- Having a contraindication to hypnosis (psychiatric disorders, psychosis)
- Treated by a systemic treatment for their AD.
The study team makes the final eligibility decision.
Where it's taking place
- Saint-Denis, Reunion
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Saint-Denis, Reunion. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.